Raised plasma aldosterone level in CHF contributes
to disease progression by exerting the following
effects except:
A. Fibrotic remodeling of myocardium
B. Hyperkalemia and hypermagnesemia
C. Increasing cardiac preload by Na+ and water
retention
D. Enhancing cardiotoxicity of sympathetic
overactivity
to disease progression by exerting the following
effects except:
A. Fibrotic remodeling of myocardium
B. Hyperkalemia and hypermagnesemia
C. Increasing cardiac preload by Na+ and water
retention
D. Enhancing cardiotoxicity of sympathetic
overactivity